Metraipolis › archive › dc_147b16889e5e

KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan-Cancer Analysis — Europe PMC PMID:42035289

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42035289
DOI
10.1155/bmri/6916290
License (as archived)
solo-consultazione
Archived
2026-11-07T06:46:50.611Z
SHA-256 of the archived text
4c139bb1241cc029c6a89cc2043d5e30fdd5c97f998a859fe8c3a5c5a1c9e1dc
Stable URL of this page
https://metraipolis.com/documento/dc_147b16889e5e

How to cite

KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan-Cancer Analysis — Europe PMC PMID:42035289 — Europe PMC (en), https://europepmc.org/article/MED/42035289 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_147b16889e5e (Metraipolis archive dc_147b16889e5e, sha256 4c139bb1241cc029c6a89cc2043d5e30fdd5c97f998a859fe8c3a5c5a1c9e1dc)
BibTeX
@misc{dc147b16889e5e,
  title = {KDM3B Predicts Expression Signature, Prognosis Value, and Immune Characteristics of Cancers: A Pan-Cancer Analysis — Europe PMC PMID:42035289},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42035289},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_147b16889e5e; sha256 4c139bb1241cc029c6a89cc2043d5e30fdd5c97f998a859fe8c3a5c5a1c9e1dc},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42035289. Agents can read the archived copy with the MCP tool read_document.